Open-Label Extension Study Comparing Latanoprost 0.005% Without vs With Benzalkonium Chloride in Open-Angle Glaucoma or Ocular Hypertension

Open-Label Extension Study Comparing Latanoprost 0.005% Without vs With Benzalkonium Chloride in Open-Angle Glaucoma or Ocular Hypertension

Bridgitte Shen Lee,1 Ranjan Malhotra,2 Kenneth Sall,3 Brittany Mitchell,4 James Peace5 1Vision Optique, Houston, TX, USA; 2Ophthalmology Associates, St. Louis, MO, USA; 3Sall Research Medical Center, Inc., Artesia, CA, USA; 4Medical Affairs North America, Sun Pharmaceutical Industries, Inc., Princet...

Full description

Bibliographic Details
Main Authors: Shen Lee B, Malhotra R, Sall K, Mitchell B, Peace J
Format: Article
Language:English
Published: Dove Medical Press 2022-07-01
Series:Clinical Ophthalmology
Subjects:
adverse events
intraocular pressure
preservative
prostaglandin
safety
tolerability
Online Access:https://www.dovepress.com/open-label-extension-study-comparing-latanoprost-0005-without-vs-with--peer-reviewed-fulltext-article-OPTH

Internet

https://www.dovepress.com/open-label-extension-study-comparing-latanoprost-0005-without-vs-with--peer-reviewed-fulltext-article-OPTH

Similar Items